Immuneering Corporation

NASDAQ

IMRX

Stock

Yield per half year: -4.52%
Dividend yield: 0%
Sector: Healthcare

Compare companies

Download the report:

Excel

Word

PDF

	Immuneering Corporation	Gilead Sciences	Amgen
Capitalization
Price	1.9	116.2	306.58
Price priv.
Number of shares, million	29.98	1255	541
Capitalization, billion	0	94.55	140.05
EBITDA, billion	-0.0637	4.43	13.36
EV, billion	0.034	132.19	189.13
Profit and loss report
Net profit, billion	-0.061	0.48	4.09
Revenue, billion	0	28.75	33.42
EPS	-2.04	0.3825	7.56
Balance
Assets, billion	0.0527	59	91.84
Debt, billion	0.0042	26.71	60.1
Balance cost, billion	0.0414	19.33	5.88
Cash, billion	0.0361	9.99	11.97
Coefficients
Dividend yield, %	0	3.17	2.94
Dividend	0	3.12	9.26
Dividend yield priv., %	0	0	0
Dividend priv.	0	0	0
Dividends/profit, %	0	816.25	118.14
P/S	467155.72	4.02	4.22
P/BV	1.59	6	23.99
P/E	0	240.57	34.48
Ev/Ebitda	-0.5335	29.81	14.16
Debt/Ebitda	-0.0654	6.02	4.5
Efficiency
ROE	-92.51	2.28	67.55
ROA	-78.61	0.7926	4.33
ROIC	0	11.06	17
Ebitda margin	-13996923.08	15.42	39.96
Net margin	-11752004.84	1.67	12.24
Momentum
1 week, price changes	-12.44 %	+7.31 %	+3.62 %
1 month, price changes	+23.38 %	+3.98 %	+2.8 %
3 months, price changes	+47.29 %	+8.86 %	+12.75 %
6 months, price changes	-4.52 %	+8.08 %	-2.9 %
1 year, price changes	+68.14 %	+30.89 %	-2.89 %
3 years, price changes	-68.33 %	+43.03 %	+15.98 %
5 years, price changes		+77.46 %	+19.95 %
10 years, price changes		+77.16 %	+95.67 %

More data >>

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe